OBJECTIVES: The objectives of this study were to determine what volume of a microbicide placebo gel is acceptable when applied intrarectally before receptive anal intercourse (RAI); and to evaluate responses to properties of the gel, its application, and its use. STUDY DESIGN: HIV-uninfected men who reported unprotected RAI with serodiscordant or unknown-status partners were enrolled in a volume escalation trial. RESULTS: Up to 35 mL of gel with the physical properties of Femglide (transparent and odorless) was acceptable to the majority of participants. Choice of different levels of viscosity may be needed. For some men, volumes judged acceptable when tried without intercourse were not acceptable when used during sex. Overall, participants reported high intentions to use microbicides when available. Condom use was inconsistent despite advice to use condoms. CONCLUSIONS: Microbicides that would require up to 35 mL of volume to be effective would be acceptable to men who engage in high-risk RAI.
Rectal microbicide acceptability: results of a volume escalation trial. Publishing Authors By Initials
Rectal microbicide acceptability: results of a volume escalation trial. Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Extr
Journal: Sexually transmitted diseases
VOLUME: 34
Page Numbers: 224-9
Journal Abbreviation:
ISSN: 0148-5717
DAY: 3
MONTH: Apr
YEAR: 2007
Rectal microbicide acceptability: results of a volume escalation trial. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 7705941
Rectal microbicide acceptability: results of a volume escalation trial. Keywords Mesh Terms:
KEYWORDS: Unsafe Sex
MESH TERMS: prevention & control
Chemical & Substance for Abstract: Rectal microbicide acceptability: results of a volume escalation trial. Information
Substance Name: Gels
Registry Number: 0
Grant and Affiliation Information for Rectal microbicide acceptability: results of a volume escalation trial.
AFFILIATION: HIV Center for Clinical and Behavioral Studies at New York State Psychiatric Institute and Columbia University, New York, NY 10032, and Miriam Hospital/Brown University, Providence, RI, USA. ac72@columbia.edu
Country: United States
AGENCY: United States PHS
GRANT: R01 046060-01
ACRONYM:
MEDLINETA: Sex Transm Dis
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Rectal microbicide acceptability: results of a volume escalation trial Related Publications